// App-Quantinova.ai

3324 : A Retrospective Single-Centre Cohort Study Comparing Lower-Dose Intravenous Immune Globulin (IVIg) (1 g/kg) to Higher-Dose Ivig (2 g/kg) in Adult Immune Thrombocytopenia

Researchers

Presenter

  • Sophie Yu Wang

Principal Investigators

  • Ribeka Kim

  • Kate M Chipperfield

  • David Pi

  • Luke Y. C. Chen

Medical Centers

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • Department of Physiotherapy, Vancouver General Hospital, Vancouver, Canada

  • Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Immune globulin

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved